Announcements Trials
Browse Landscape

Phase

Phase NA 21Phase 2 16Phase 3 3Phase 4 2Phase 2/3 2Phase 1/2 1Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 23NIH 3OTHER_GOV 2UNKNOWN 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 4Neoplasms 3Rectal Neoplasms 2Prostatic Neoplasms 2Polycystic Ovary Syndrome 2Leukemia, Myeloid, Acute 2Carcinoma, Hepatocellular 2Weight Loss 1Warts 1Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Recurrence 1Pancreatic Neoplasms 1Pain 1Ovarian Neoplasms 1Osteosarcoma 1Oesophagogastric Cancer 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lung Neoplasms 1Leukopenia 1Leukemia, Promyelocytic, Acute 1Leukemia, Biphenotypic, Acute 1Insulin Resistance 1Infertility 1Immunotherapy Gastrict Cancer 1Hydatidiform Mole 1Glioma 1

Interventions

XELOX 1Folfox protocol 1Fluorouracil 1Drug Therapy 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × OTHER_GOV × Rectal Neoplasms × Clear all
NCT03957733 2022-04-06

Phase II/III Study to Assess the Efficacy of Neoadjuvant Consolidation Chemotherapy in Rectal Cancer Patients.

King Abdullah Medical City

Phase 2/3 Unknown
338 enrolled
Gastrointestinal

Rectal Neoplasms

NCT03428529 2018-02-09

INCAGI004

Instituto Nacional de Cancer, Brazil

Phase 2/3 Completed
63 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡